Cuiping Zhang

Dr. Cuiping Zhang


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
YWYaxi Wang
Yaxi Wang
ZCZhen Cao
Zhen Cao
QWQian Wei
Qian Wei
KMKui Ma
Kui Ma
WHWenzhi Hu
Wenzhi Hu
XFXiaobing Fu
Xiaobing Fu

13 February 2023 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
QLQiankun Li
Qiankun Li
WHWenzhi Hu
Wenzhi Hu
QHQilin Huang
Qilin Huang
JYJie Yang
Jie Yang
BLBingmin Li
Bingmin Li
CZCuiping Zhang
Cuiping Zhang
Unhealable diabetic wounds need to be addressed with the help of newer, more efficacious strategies. Exosomes combined with biomaterials for sustained delivery of therapeutic agents are expected to bring new hope for chronic wound treatment. Here, the engineered exosomes modified for efficiently loading miR146a and attaching to silk fibroin patch (SFP) were demonstrated to promote diabetic wound healing. Silk fibroin binding peptide (SFBP) was screened through phage display, and SFBP-Gluc-MS2 (SGM) and pac-miR146a-pac fusion protein were constructed. The designed exosomes (SGM-Exos, miR146a-Exos, and SGM-miR146a-Exos) were isolated from the engineered placental mesenchymal stem cells (PMSCs) transduced with SGM or/and pac-miR146a-pac protein. Gluc signals indicated SGM-Exo@SFP markedly increased the binding rate and the stability of SGM-Exo. Moreover, the loading efficiency of miR146a in SGM-miR146a-Exos was ten-fold higher than that in miR146a-Exos. Superior to untreated, SGM-miR146a-Exo-only treated, and SFP-only treated groups, SGM-miR146a-Exo@SFP drived wound healing associated with less inflammation, collagen deposition, and neovascularization. The transcriptomics analysis suggested anti-inflammatory and regenerative effects with SGM-miR146a-Exo@SFP treatment. Here, we show efficient exosome@biomaterial-based miRNA delivery systems for regenerative medicine and tissue engineering.

16 February 2025 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
HMHao Meng
Hao Meng
JSJianlong Su
Jianlong Su
QSQi Shen
Qi Shen
WHWenzhi Hu
Wenzhi Hu
PLPinxue Li
Pinxue Li
CZCuiping Zhang
Cuiping Zhang

3 June 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
XBXiaowei Bian
Xiaowei Bian
KMKui Ma
Kui Ma
CZCuiping Zhang
Cuiping Zhang
XFXiaobing Fu
Xiaobing Fu
Ischemic diseases, which are caused by a reduction of blood supply that results in reduced oxygen transfer and nutrient uptake, are becoming the leading cause of disabilities and deaths. Therapeutic angiogenesis is key for the treatment of these diseases. Stem cells have been used in animal models and clinical trials to treat various ischemic diseases. Recently, the efficacy of stem cell therapy has increasingly been attributed to exocrine functions, particularly extracellular vesicles. Extracellular vesicles are thought to act as intercellular communication vehicles to transport informational molecules including proteins, mRNA, microRNAs, DNA fragments, and lipids. Studies have demonstrated that extracellular vesicles promote angiogenesis in cellular experiments and animal models. Herein, recent reports on the use of extracellular vesicles for therapeutic angiogenesis during ischemic diseases are presented and discussed. We believe that extracellular vesicles-based therapeutics will be an ideal treatment method for patients with ischemic diseases.

29 January 2024 in Advanced Science
Verified
Journal Article
Open access
QWQian Wei
Qian Wei
JSJianlong Su
Jianlong Su
SMSheng Meng
Sheng Meng
YWYaxi Wang
Yaxi Wang
KMKui Ma
Kui Ma
CZCuiping Zhang
Cuiping Zhang
Delayed wound healing is a major complication of diabetes, and is associated with impaired cellular functions. Current treatments are unsatisfactory. Based on the previous reports on microRNA expression in small extracellular vesicles (sEVs), miR‐17‐5p‐engineered sEVs (sEVs 17‐OE ) and encapsulated them in gelatin methacryloyl (GelMA) hydrogel for diabetic wounds treatment are fabricated. SEVs 17‐OE are successfully fabricated with a 16‐fold increase in miR‐17‐5p expression. SEVs 17‐OE inhibited senescence and promoted the proliferation, migration, and tube formation of high glucose‐induced human umbilical vein endothelial cells (HG‐HUVECs). Additionally, sEVs 17‐OE also performs a promotive effect on high glucose‐induced human dermal fibroblasts (HG‐HDFs). Mechanism analysis showed the expressions of p21 and phosphatase and tensin homolog (PTEN), as the target genes of miR‐17‐5p, are downregulated significantly by sEVs 17‐OE . Accordingly, the downstream genes and pathways of p21 and PTEN, are activated. Next, sEVs 17‐OE are loaded in GelMA hydrogel to fabricate a novel bioactive wound dressing and to evaluate their effects on diabetic wound healing. Gel‐sEVs 17‐OE effectively accelerated wound healing by promoting angiogenesis and collagen deposition. The cellular mechanism may be associated with local cell proliferation. Therefore, a novel bioactive wound dressing by loading sEVs 17‐OE in GelMA hydrogel, offering an option for chronic wound management is successfully fabricated.

4 May 2021 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
QWQian Wei
Qian Wei
YWYaxi Wang
Yaxi Wang
KMKui Ma
Kui Ma
QLQiankun Li
Qiankun Li
BLBingmin Li
Bingmin Li
CZCuiping Zhang
Cuiping Zhang